World Cancer Day
4 FEBRUARY 2016 / It is estimated that there are 14 million new cancer cases around the world each year, and 8 million cancer-related deaths. Each year on 4 February, WHO and the International Agency for Research on Cancer (IARC) supports the Union for International Cancer Control (UICC) to promote ways to ease the global burden of cancer.
We can. I can -- "Talking hands" on social media
To encourage not only organisations and corporates to mark the Day but also individuals, the Union for International Cancer Control (UICC) – the custodians of World Cancer Day – has launched a social media campaign to raise awareness of the Day and the World Cancer Day campaign theme ‘We can. I can.’ as a collective or as individuals – do our part to reduce the global burden of cancer. Everyone --- individuals, patients, survivors, advocates, organizations, corporations, health professional –are invited to join the social media ‘Talking hands’ campaign. #WorldCancerDay and #WecanIcan
EWEC: Cervical cancer highlighted
The Every Woman Every Child (EWEC) movement is joining forces to shed light on cervical cancer -- a condition that severely affects women’s health, killing and devastating the lives of thousands worldwide. Together with global health advocates and following a special screening of the movie Lady Ganga on 4 February at the United Nations in New York, EWEC partners and experts are discussing how the international community can help end cervical cancer— an almost always preventable disease, mainly caused by viral infections, the leading cause of cancer deaths in low- and middle-income countries. Moreover, as cervical cancer is a significant risk factor for acquiring HIV and vice versa, the prevention and control of cervical cancer is closely linked to the fight against HIV/AIDS.
Improving access to medicines for cancer treatment through the WHO Model List of Essential Medicines (EML)
It is estimated that there are 14 million new cancer cases around the world each year, and 8 million cancer-related deaths. The burden of both morbidity and mortality falls largely on the developing world. Only 2 generations ago, there were very few medicines available to treat cancer. But our understanding of cancer biology has advanced significantly, and therapeutic options have diversified tremendously since. Today, our toolkit to treat cancer patients is vast – from conventional chemotherapies, to immunotherapies, hormone treatment, and other targeted therapies. In 2015, the WHO developed a toolbox designed to support countries in decision-making for developing national formularies and cancer control planning, published in 2015.